Company Filing History:
Years Active: 2017-2021
Title: The Innovations of Michael Moses
Introduction
Michael Moses is an accomplished inventor based in Graevenwiesbach, Germany. He has made significant contributions to the field of medical science, particularly in the area of blood coagulation disorders. With a total of three patents to his name, Moses has demonstrated a commitment to advancing healthcare solutions.
Latest Patents
Moses's latest patents include a modified von Willebrand factor that boasts an improved half-life. This invention relates to a modified VWF molecule designed for use in the treatment of blood coagulation disorders. Another notable patent is focused on sugar compositions for treating hemophilia A and/or von Willebrand disease. This invention involves compositions comprising an isolated sugar that is derived from ABO(H) blood group antigens, aimed at providing effective treatment options for these conditions.
Career Highlights
Throughout his career, Michael Moses has worked with prominent companies in the biotechnology sector, including CSL Behring GmbH and CSL Behring Lengnau AG. His work in these organizations has allowed him to contribute to innovative solutions in the treatment of blood disorders.
Collaborations
Moses has collaborated with notable professionals in his field, including Stefan Schulte and Rolf Spirig. These partnerships have further enhanced his research and development efforts.
Conclusion
Michael Moses is a notable inventor whose work has significantly impacted the treatment of blood coagulation disorders. His innovative patents and collaborations reflect his dedication to improving healthcare solutions.